Immunotherapy-mediated dermatological adverse events: the urgent need for a common, clinically meaningful, management strategy.
| Publicado en: | Supportive Care in Cancer Vol. 28; no. 12; pp. 5597 - 5600 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=147180146&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 147180146 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09414355 O1J jtl: Supportive Care in Cancer issn: 09414355 maglogo: N pubinfo: dt: 2020 vid: 28 iid: 12 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 147180146 145228250 10.1007/s00520-020-05701-9 147180146 ppf: 5597 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Immunotherapy-mediated dermatological adverse events: the urgent need for a common, clinically meaningful, management strategy. aug: au: Apalla, Zoe Sibaud, Vincent affil: Second Dermatology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|